Statin Monotherapy and Rosuzet Tab.(Rosuvastatin/Ezetimibe) Administration in Patients With Dyslipidemia in Korea

NCT04829149 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 5717

Last updated 2021-04-02

No results posted yet for this study

Summary

A Cohort Study for Comparison of Statin Monotherapy and Rosuzet Tab.(Rosuvastatin/Ezetimibe) Administration and Statin Prescription Patterns in Patients With Dyslipidemia in Korea.

Conditions

  • Dyslipidemias

Interventions

OTHER

Observational

Statin therapy group and Rosuzet tablet group

Sponsors & Collaborators

  • Hanmi Pharmaceutical Company Limited

    lead INDUSTRY

Principal Investigators

  • Mi-Jeung KIM · Hanmi Pharmaceutical Company Limited

Eligibility

Min Age
19 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-06-14
Primary Completion
2019-06-01
Completion
2019-08-29

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04829149 on ClinicalTrials.gov